as on December 20, 2025 at 2:29 am IST
Day's Low
Day's High
0.66%
Downside
6.62%
Upside
52 Week's Low
52 Week's High
34.46%
Downside
138.41%
Upside
Check Macrogenics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$99.3M
EPS (TTM)
-0.885
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.70%
PE Ratio (TTM)
-1.6
Industry PE ratio
-3.2295762711864406
PEG Ratio
0.01
EBITDA
-106.1M
Revenue (TTM)
127.6M
Profit Margin
-59.46%
Return On Equity TTM
-81.13%
Track how Macrogenics, Inc. P/E has moved over time to understand its valuation trends.
Macrogenics, Inc. in the last 5 years
Lowest (-12.96x)
June 30, 2021
Industry (-3.23x)
December 20, 2025
Today (-1.60x)
December 20, 2025
Highest (-0.92x)
September 30, 2025
Today’s Price to Earnings Ratio: -1.60x
Compare market cap, revenue, PE, and other key metrics of Macrogenics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $99.3M | -94.06% | -1.6 | -59.46% | |
| BUY | $37.3B | 371.01% | -16.34 | -264.83% | |
| BUY | $52.3B | 181.08% | 1237.62 | 1.36% | |
| BUY | $114.7B | 92.72% | 31.44 | 31.35% | |
| BUY | $79.4B | 53.93% | 17.95 | 32.13% |
The Macrogenics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Macrogenics, Inc. investment value today
Current value as on today
₹52,716
Returns
Returns from Macrogenics, Inc. Stock
Dollar Returns*
₹5,231 (+5.23%)
Based on 18 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Macrogenics, Inc.. Average target price of $3.4
Get share price movements and forecasts by analysts on Macrogenics, Inc..
What analysts predicted
55.59%UPSIDE
Target Price
$3.4
Current Price
$1.51
Analyzed by
18 Analysts
Target
$3.40
Macrogenics, Inc. target price $3.4, a slight upside of 55.59% compared to current price of $1.51. According to 18 analysts rating.
Search interest for Macrogenics, Inc. Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 13.19M → 72.83M (in $), with an average increase of 55.1% per quarter
Price Rise
![]()
In the last 7 days, MGNX stock has moved up by 7.1%
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -41.03M → 16.82M (in $), with an average increase of 164.4% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 148.2% return, outperforming this stock by 201.0%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 779.0% return, outperforming this stock by 854.0%
| Organisation | Macrogenics, Inc. |
| Headquarters | 9704 Medical Center Drive, Rockville, MD, United States, 20850 |
| Industry | Health Technology |
| CEO | Mr. Eric Blasius Risser |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Steve Harig | Senior Vice President of Human Resources |
Mr. Harish Krishnaswamy | Senior Vice President of Business Development & Portfolio Planning |
Ms. Beth Smith | VP, Controller & Treasurer |
Mr. James Karrels | Senior VP, CFO & Corporate Secretary |
Dr. Stephen L. Eck M.D., Ph.D. | Senior VP of Clinical Development & Chief Medical Officer |
Mr. Jeffrey Stuart Peters J.D. | Senior VP, General Counsel & Corporate Compliance Officer |
Mr. Eric Blasius Risser | CEO, President & Director |
Dr. Thomas M. Spitznagel Ph.D. | Senior Vice President of Technical Operations |
Dr. Ezio Bonvini M.D. | Senior VP of Research & Chief Scientific Officer |
Macrogenics, Inc. share price today is $1.51 as on at the close of the market. Macrogenics, Inc. share today touched a day high of $1.61 and a low of $1.5.
Macrogenics, Inc. share touched a 52 week high of $3.6 on and a 52 week low of $0.99 on . Macrogenics, Inc. stock price today i.e. is closed at $1.51,which is 58.06% down from its 52 week high and 52.58% up from its 52 week low.
Macrogenics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Macrogenics, Inc. (MGNX) shares with as little as ₹89.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Macrogenics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Macrogenics, Inc. share’s latest price of $1.51 as on December 20, 2025 at 2:29 am IST, you will get 6.6225 shares of Macrogenics, Inc.. Learn more about
fractional shares .
Macrogenics, Inc. stock has given -94.06% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?